• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

AI Meets Value-Based Care: Cleerly and Cardiac Care Alliance Join Forces

by Jasmine Pennic 05/06/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Cleerly, a leader in cardiovascular imaging, and Cardiac Care Alliance, a prominent figure in value-based cardiovascular care solutions, today announced a strategic partnership aimed at significantly enhancing cardiovascular care delivery. 

– The collaboration will see the integration of Cleerly’s advanced AI-powered coronary artery assessment technology into Cardiac Care Alliance’s extensive cardiovascular care network. The initiative is set to launch initially with cardiology practices in Texas, with ambitions for broader implementation.

Optimizing Cardiac Pathways with Advanced AI Technology

A key objective of this partnership is to refine the diagnostic journey for patients with cardiovascular symptoms. Cardiac Care Alliance will incorporate Cleerly’s Artificial Intelligence–Quantitative Coronary Tomography (AI-QCT) technology into its offerings for payers and practices. The goal is to ensure that symptomatic patients, when appropriate, undergo Cleerly’s noninvasive assessment prior to considering cardiac catheterization procedures. This strategic sequencing aims to direct the right patients to the catheterization laboratory while helping others avoid unnecessary invasive testing and the associated costs.

Cleerly’s AI-QCT technology provides a comprehensive and standardized assessment of coronary artery disease based on noninvasive Cardiac Computed Tomography Angiography (CCTA). Studies have demonstrated its high accuracy in evaluating the presence, extent, and composition of coronary atherosclerotic plaque, reportedly superior to consensus readings from Level 3 Expert Physician Readers¹.

“We’re always seeking ways to expand access to life-saving heart care, and by combining our networks, both organizations can reach more providers and patients,” said Prakash Patel, MD, CEO and Chairman of Cardiac Care Alliance. “This partnership represents our commitment to providing solutions that are both clinically effective and economically sustainable. Cardiovascular disease currently costs the US healthcare system approximately $233 billion annually, and is the most costly chronic condition in the US, roughly 11% of total healthcare expenditures². Delivering care that can provide early detection and guide clinical decisions to the right interventions to improve outcomes and reduce unnecessary costs, are critical to addressing this growing healthcare challenge.”

Phased Rollout 

The partnership will initially launch with select cardiology practices in Texas, serving as a foundation for future expansion. Both Cleerly and Cardiac Care Alliance are optimistic that this integrated approach will set a new standard in cardiovascular care, ultimately benefiting patients by improving outcomes and making care more sustainable.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Value-Based Care

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |